Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
- DOI
- 10.1159/000535285
- Published
- 2024
- Container
- Dermatology (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1159/000535285,
title = {Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.},
author = {Thyssen JP and Bewley A and Ständer S and Castro C and Misery L and Kim BS and Biswas P and Chan G and Myers DE and Watkins M and Alderfer J and Güler E and Silverberg JI},
year = {2024},
journal = {Dermatology (Basel, Switzerland)},
doi = {10.1159/000535285},
url = {https://doi.org/10.1159/000535285}
}RIS
TY - JOUR TI - Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis. AU - Thyssen JP AU - Bewley A AU - Ständer S AU - Castro C AU - Misery L AU - Kim BS AU - Biswas P AU - Chan G AU - Myers DE AU - Watkins M AU - Alderfer J AU - Güler E AU - Silverberg JI PY - 2024 JO - Dermatology (Basel, Switzerland) DO - 10.1159/000535285 UR - https://doi.org/10.1159/000535285 ER -
APA
JP, T., A, B., S, S., C, C., L, M., BS, K., P, B., G, C., DE, M., M, W., J, A., E, G., & JI, S. (2024). Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.. Dermatology (Basel, Switzerland). https://doi.org/10.1159/000535285
Source records
- pubmed · retrieved 2026-09-24T18:36:38.769Z